USE OF A THERAPEUTICALLY EFFECTIVE AMOUNT OF BB-12 AND LGG IN THE PREPARATION OF A MEDICAMENT FOR PREVENTING OR TREATING RESPIRATORY INFECTIONS AND ACUTE OTITIS MEDIA IN INFANTS

摘要

The present invention is directed to a novel method for preventing or treating respiratory infections and acute otitis media in infants. The method comprises the administration of a therapeutically effective amount of a Bifidobacteria strain and an adherence-promoting probiotic, such as LGG, to the infant.